Home
Company
Products
Strategy
- Strategic Goals
Partnering
Sustainability
- Sustainability Overview
- Reports
Media
- Events & Presentations
- News
COVID-19
Contact

Addressing_superbug_concern

May 27, 2020

Addressing_superbug_concern

Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses

Categories

Company News (18)
Proteon General News (3)

Recent Posts

Proteon Pharmaceuticals Secures 21 million Euro to Accelerate Growth
Proteon Pharmaceuticals pozyskał 21 mln Euro na przyśpieszenie rozwoju
EFSA CONFIRMS SAFETY OF BAFASAL®, A “FIRST IN CLASS”, INNOVATIVE FEED ADDITIVE
Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture
Proteon Pharmaceuticals – strategiczne partnerstwo handlowe z DuPont Animal Nutrition

Our Solutions

170131_salmonellafree_logo_456x181-e1486970860523

Contact Proteon

Your Name

Your Email

Subject *

Message *

Follow Us —

Company

Mission
Management Team
Locations
Investors
Awards

Products

Product Overview
Bafasal®
Bafador®
Product Pipeline

Partnering

Co-Development
Become a Distributor
Grants

Strategy

Strategic Goals

Sustainability

Overview
Reports

Media

Events & Presentations
Media About Us
News

logo_proteon-white

CUSTOMER SERVICE: +48 502-678-674 | proteon@proteonpharma.com

Privacy Policy | Polityka Prywatności

Copyright © 2019 Proteon Pharmaceuticals, All Rights Reserved